Small Fiber Neuropathy in Patients With Latent Autoimmune Diabetes in Adults: Table 1 | Zendy

Uazman Alam | Zendy; Omar Asghar | Zendy; Ioannis N. Petropoulos | Zendy; Maria Jeziorska | Zendy; Hassan Fadavi | Zendy; Georgios Ponirakis | Zendy; Andrew Marshall | Zendy; Mitra Tavakoli | Zendy; Andrew J.M. Boulton | Zendy; Nathan Efron | Zendy; Rayaz A. Malik | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Small Fiber Neuropathy in Patients With Latent Autoimmune Diabetes in Adults: Table 1

Author(s) -

Uazman Alam,

Omar Asghar,

Ioannis N. Petropoulos,

Maria Jeziorska,

Hassan Fadavi,

Georgios Ponirakis,

Andrew Marshall,

Mitra Tavakoli,

Andrew J.M. Boulton,

Nathan Efron,

Rayaz A. Malik

Publication year - 2015

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc14-2354

Subject(s) - medicine , diabetes mellitus , autoimmune diabetes , autoimmune disease , diabetic neuropathy , type 1 diabetes , endocrinology , disease

The prevalence of latent autoimmune diabetes in adults (LADA) in patients diagnosed with type 2 diabetes mellitus (T2DM) ranges from 7 to 10% (1). They present at a younger age and have a lower BMI but poorer glycemic control, which may increase the risk of complications (2). However, a recent analysis of the Collaborative Atorvastatin Diabetes Study (CARDS) has demonstrated no difference in macrovascular or microvascular events between patients with LADA and T2DM, but neuropathy was not assessed (3). Previous studies quantifying neuropathy in patients with LADA are limited. In this study, we aimed to accurately quantify neuropathy in subjects with LADA compared with matched patients with T2DM

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research